Company research / AEMD

Aethlon Medical Inc (AEMD)

SEC name AETHLON MEDICAL INC · CIK 0000882291 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

Key ratios (year ended 2026-03-31)

-146.4%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-15

Headquarters locality: San Diego · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-10, first reflected in a filing dated 2023-11-14; 1-for-8, first reflected in a filing dated 2025-06-26; 1-for-50, first reflected in a filing dated 2026-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenuen/an/an/a$0$574.2K$294.2K$659.1K$650.2K$229.6K$149.6K$392.1K
R&D Expensen/a$1.91M$2.21M$2.52M$2.75M$2.34M$2.07M$927.0K$896.0K$586.0K$673.0K
Operating Income-$7.08M-$7.29M-$9.34M-$12.64M-$11.90M-$10.42M-$7.89M-$5.93M-$6.00M-$4.83M-$6.10M
Depreciation & Amortization$313.9K$323.7K$339.6K$359.1K$240.9K$123.7K$39.9K$26.4K$30.7K$35.7K$32.4K
EBITDA-$6.77M-$6.97M-$9.00M-$12.28M-$11.66M-$10.30M-$7.85M-$5.90M-$5.97M-$4.80M-$6.07M
Net Income-$6.94M-$7.15M-$13.39M-$12.21M-$12.03M-$10.42M-$7.89M-$6.37M-$6.19M-$5.68M-$7.28M
EPS (Diluted)n/a-$10.61-$85.77-$38.87-$5.86-$0.71n/an/an/an/an/a
Total Assets$6.24M$6.33M$7.36M$8.25M$17.51M$19.42M$10.67M$10.39M$4.12M$7.35M$1.73M
Total Liabilitiesn/a$1.45M$2.24M$2.48M$2.44M$2.43M$1.38M$1.11M$1.82M$1.32M$1.13M
Shareholders' Equity$5.20M$4.89M$5.12M$5.77M$15.06M$17.13M$9.43M$9.41M$2.43M$6.13M$676.4K
Cash & Equivalents$4.93M$5.03M$5.50M$5.44M$14.53M$17.07M$9.86M$9.60Mn/an/an/a
Operating Cash Flow-$7.18M-$7.00M-$7.65M-$10.13M-$10.51M-$9.77M-$6.76M-$5.20M-$4.29M-$3.91M-$3.51M
Capital Expenditures$12.9K$3.7K$0$250.9K$943.1K$349.2K$59.9K$151.7K$0$24.8K$16.4K
Free Cash Flow-$7.19M-$7.00M-$7.65M-$10.38M-$11.45M-$10.12M-$6.82M-$5.35M-$4.29M-$3.94M-$3.52M
Shares Outstanding477.4K1.57M201.1K328.7K2.30M15.42M12.15M9.37M1.27M17.74M8.80M
Weighted Average Diluted Sharesn/a673.9K156.1K314.1K2.05M14.76Mn/an/an/an/an/a
EPS (Basic)n/a-$10.61-$85.77-$38.87-$5.86-$0.71n/an/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView